Northern climes make a difference with growth hormone treatment

October 28, 2015 by Jamie Brown, University of Manchester

The rate of growth in children varies with the season while higher latitude and greater summer daylight exposure makes a significant difference in results for children treated with growth hormone, according to new research from The University of Manchester.

The study of with deficiency from 14 countries measured their rate of growth for a year whilst being treated and mapped their response against the amount of summer typical to the latitude at which they live.

High latitude – northerly in the northern hemisphere and the reverse in the south – has already been shown to result in people being generally taller, even over relatively short distances, such as between southern and northern Japan. This effect also appears to be seasonal, with children growing faster during the summer.

But it has not been known if this happens when children are treated for a deficiency in growth hormone or how the interaction between sunlight and genetics works.

Dr Adam Stevens from the laboratory of Professor Peter Clayton in the University's Institute of Human Development and the Central Manchester University Hospitals NHS Foundation Trust, led the study. He said: "Growth hormone deficiency is a treatable condition but effectiveness can vary.

"By understanding the reasons for this and how the body responds to where the patient lives, we can begin to investigate ways of making therapy more efficient and predictable."

The study showed that there is a complex relationship between growth and the body's circadian clock which causes variation in gene expression. Genes which affect bone growth, and other growth mechanisms were shown to vary dependent on latitude and the time of year, suggesting that seasonal differences are caused by the amount of sunlight the children were receiving.

All of the 118 children in the study were aged around 5-11 years old and came from mainly European nations. A third came from other countries such as Argentina, Taiwan and South Korea. It was assumed that they lived close to the testing centre as this was used for their latitude measurement. All were pre-pubescent and were being given the hormone r-hGH for the first time.

Dr Stevens said: "Growth response to this treatment appears to be related to both daylight and genetics. The information we collected about how genes are expressed in each patient suggests that growth in this group was driven by the exposure they had to sunlight.

"The complex relationship between the patients' genes and where they live has a major bearing on how they react to growth hormone."

The paper, 'Effect of Summer Daylight Exposure and Genetic Background on Growth in Growth Hormone Deficient (GHD) Children' was published in The Pharmacogenomics Journal.

Explore further: Growth hormone reverses growth problems in children with kidney failure

More information: C De Leonibus et al. Effect of summer daylight exposure and genetic background on growth in growth hormone-deficient children, The Pharmacogenomics Journal (2015). DOI: 10.1038/tpj.2015.67

Related Stories

Growth hormone reverses growth problems in children with kidney failure

April 4, 2013
Growth hormone therapy can help reverse growth problems in children with kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). However, ...

Growth hormone treatment for children may exacerbate feelings of depression

June 23, 2014
Short, otherwise healthy children who are treated with growth hormone (GH) may become taller, but they may also become more depressed and withdrawn over time, compared to children the same age and height who are not treated ...

Growth hormone reduces risk of osteoporosis fractures in older women

August 27, 2015
For years after it was administered, growth hormone continued to reduce the risk of fractures and helped maintain bone density in postmenopausal women who had osteoporosis, according to a new study published in the Endocrine ...

Growth hormone related with signs of aging

June 16, 2014
The decreased production of growth hormone is caused by a physiological process known as somatopause, which practically affects the entire body, since it's involved in body composition, metabolism, bone mineral density and ...

New growth charts developed for US children with Down syndrome

October 27, 2015
Pediatric researchers have developed the first set of growth charts for U.S. children with Down syndrome since 1988. These new charts provide an important tool for pediatricians to evaluate growth milestones for children ...

Recommended for you

Researchers identify blood biomarkers that may help diagnose, confirm concussions

April 20, 2018
Researchers from the University of California, Irvine, Georgetown University and the University of Rochester have found that specific small molecules in blood plasma may be useful in determining whether someone has sustained ...

DOR protein deficiency favors the development of obesity

April 20, 2018
Obesity is a world health problem. Excessive accumulation of fat tissue (adipose tissue) increases the risk of cardiovascular disease, hypertension, diabetes and some types of cancer. However, some obese individuals are less ...

Stem-cell technology aids 3-D printed cartilage repair

April 20, 2018
Novel stem-cell technology developed at Swinburne will be used to grow the massive number of stem cells required for a new hand-held 3-D printer that will enable surgeons to create patient-specific bone and cartilage.

Enduring cold temperatures alters fat cell epigenetics

April 19, 2018
A new study in fat cells has revealed a molecular mechanism that controls how lifestyle choices and the external environment affect gene expression. This mechanism includes potential targets for next-generation drug discovery ...

Defect in debilitating neurodegenerative disease reversed in mouse nerves

April 19, 2018
Scientists have developed a new drug compound that shows promise as a future treatment for Charcot-Marie-Tooth disease, an inherited, often painful neurodegenerative condition that affects nerves in the hands, arms, feet ...

Molecule that dilates blood vessels hints at new way to treat heart disease

April 19, 2018
Americans die of heart or cardiovascular disease at an alarming rate. In fact, heart attacks, strokes and related diseases will kill an estimated 610,000 Americans this year alone. Some medications help, but to better tackle ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.